Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling.

Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling. Abstract Text:

    carol j belfioreCarol J Belfiore,raymond s h yangRaymond S H Yang,laura s chubbLaura S Chubb,manupat lohitnavyManupat Lohitnavy,ornrat s lohitnavyOrnrat S Lohitnavy,melvin e andersenMelvin E Andersen,

    Chlordecone (CD) and mirex (M) differ by a single carbonyl group in CD in place of two chlorines in M. Although both compounds are lipophilic, their tissue distributions differ markedly: CD concentrations are highest in liver; M concentrations are highest in fat. We used tissue time course data in rats from our laboratory for CD and M and literature data from monkeys to develop PBPK models to study differences in liver and fat partitioning. The PK model for M had partitioning in tissue without specific hepatic binding. The CD model had partitioning similar to M, and also included liver binding: the maximal binding (B(max)) and binding affinity constant (Kd) required to describe the rat data were 370 nmol/g liver and 100 nM, respectively. To see if other ketones with electron withdrawing constituents at the alpha carbon were also preferentially distributed to liver, we developed a PBPK description for tissue distribution of hexafluoroacetone (HFA). Compared to acetone, HFA is known to be preferentially sequestered in liver and more slowly excreted unchanged from the body. Acetone is more equally distributed to tissues. HFA distribution was evaluated with a PBPK model that included hepatic binding. B(max) and Kd were 1.58 micromol/g liver and 301 microM. In summary, liver sequestration of CD and HFA most likely represents relatively high-affinity but reversible binding of activated carbonyls in these compounds (activated by the presence of electron withdrawing substituents on the alpha-carbons) with glutathione and glutathione transferases, that are present at much higher concentrations in liver than in other tissues. Strong, but reversible hemithioketal formation with active sulfhydryls may also be associated with the toxic responses to CD and HFA.

    Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling. Publishing Authors By Initials

    cj belfioreCJ Belfiore,rs yangRS Yang,ls chubbLS Chubb,m lohitnavyM Lohitnavy,os lohitnavyOS Lohitnavy,me andersenME Andersen,

    For similar biochemical phenomena, metabolism, and nutrition: metabolism: pharmacokinetics: tissue distribution research abstracts see: biochemical phenomena, metabolism, and nutrition: metabolism: pharmacokinetics: tissue distribution research

    PUBMED ID PMID:

    MEDLINE DATE:

    Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Toxicology

    VOLUME: 234

    Page Numbers: 59-72

    Journal Abbreviation:

    ISSN: 0300-483X

    DAY: 17

    MONTH: 02

    YEAR: 2007

    Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 361055

    Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling. Keywords Mesh Terms:

    KEYWORDS: Tissue Distribution

    MESH TERMS: pharmacokinetics

    Chemical & Substance for Abstract: Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling. Information

    Substance Name: hexafluoroacetone

    Registry Number: 684-16-2

    Grant and Affiliation Information for Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling.

    AFFILIATION: Quantitative and Computational Toxicology Group, Department of Environmental and Radiological Health Sciences, Colorado State University, Ft Collins, CO 80523, USA. carol.belfiore@comcast.net

    Country: Ireland

    Ireland Research PublicationIreland Research Publication

    AGENCY: United States NIEHS

    GRANT: T32 ES07321

    ACRONYM: ES

    MEDLINETA: Toxicology

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News